PF-06372865 in Subjects With Photosensitive Epilepsy
Public ClinicalTrials.gov record NCT02564029. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double Blind, Randomized, Cross- Over Study Examining Efficacy Of Pf-06372865 In A Photosensitivity Epilepsy Study Using Lorazepam As A Positive Control
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
PF-06372865 in subjects with photosensitive epilepsy
Study identification
- NCT ID
- NCT02564029
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 7 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 16, 2015 (Actual)
- Primary completion
- Jan 10, 2017 (Actual)
- Completion
- Feb 7, 2017 (Actual)
- Last update posted
- Mar 14, 2018
2015 – 2017
United States locations
- U.S. sites
- 16
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Consultants in Epilepsy & Neurology, PLLC | Boise | Idaho | 83702 | — |
| Johns Hopkins University Department of Neurology | Baltimore | Maryland | 21287-7247 | — |
| Barnes Jewish Hospital | St Louis | Missouri | 63110 | — |
| Center for Advanced Medicine | St Louis | Missouri | 63110 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| New York University Comprehensive Epilepsy Center | New York | New York | 10016 | — |
| Clinical and Translational Research Center | Philadelphia | Pennsylvania | 19104 | — |
| Hospital of the Univ of PA Pharmacy Service | Philadelphia | Pennsylvania | 19104 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Thomas Jefferson University Comprehensive Epilepsy Center | Philadelphia | Pennsylvania | 19107 | — |
| Thomas Jefferson University Hospital EEG lab | Philadelphia | Pennsylvania | 19107 | — |
| Thomas Jefferson University Investigational Drug Service | Philadelphia | Pennsylvania | 19107 | — |
| General Clinical Research Center (GCRC) | Nashville | Tennessee | 37232 | — |
| Vanderbilt University Epilepsy Clinic | Nashville | Tennessee | 37232 | — |
| Vanderbilt University Hospital Pharmacy | Nashville | Tennessee | 37232 | — |
| VU Department of Neurology | Nashville | Tennessee | 37232 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02564029, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 14, 2018 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02564029 live on ClinicalTrials.gov.